The azoxymethane (AOM)-induced mouse colon tumor model recapitulates many of the histopathological features associated with the multistage progression of human sporadic colorectal cancers (CRCs). To better define the genetic events associated with tumorigenesis in this murine model, we analysed tumors from A/J mice for chromosomal (CIN) and microsatellite (MSI) instabilities, two fundamental pathways of genomic instability that play a critical role in the pathogenesis of human CRCs. Male A/ J mice, 6-week old, were injected with either AOM (n ¼ 5) (10 mg/kg b.w., i.p.) or vehicle (n ¼ 5) (0.9% NaCl solution) once a week for 6 weeks. At 32 weeks after the last dose, comparative genomic hybridization (CGH) was performed on 16 tumors harvested from five animals. Although 25% of the tumors displayed either a gain of chromosome 2 or loss of Y, the majority (75%) showed no genomic imbalances. Further analysis of chromosomal aberrations, using CGH and spectral karyotyping (SKY) was performed in our recently established A/J colon tumor-derived cell line, AJ02-NM 0 . Results showed a pseudotetraploid karyotype with loss of only the Y chromosome in these cultured cells, thereby providing additional evidence for the minimal role of CIN in the primary AOM-induced tumors. Interestingly, the majority (81%) of A/J tumors displayed low-level microsatellite instability (MSI-L) when analysed using mono-and dinucleotide repeat markers, and showed a significant expansion to high-level instability (MSI-H) in the AJ02-NM 0 cells. This finding in cultured cells additionally provides evidence that a mild mutator pathway may contribute to the development of behaviorally benign carcinomas in situ in A/J mice. To better understand the tumorigenic process in the A/J colons, we screened for mutational alterations in key regions of the K-ras and Apc genes. Results showed a very low frequency (6%) of K-ras activating mutations, together with the absence of Apc truncation mutations in primary tumors and AJ02-NM 0 cells. However, these tumors displayed intense nuclear accumulation of b-catenin protein, indicating activation of the Wnt signaling pathway. Based on our molecular and cytogenetic findings, we propose that carcinogen-induced tumors may develop via mechanisms independent of the 'classical' CIN or MSI pathways.
Introduction
Colorectal cancer (CRC) is the second leading cause of cancer deaths in the US. Although significant molecular insights have been gained by a direct analysis of human CRCs, animal models provide an important experimental tool for elucidating the early molecular alterations that underlie the pathogenesis of both familial and nonfamilial (sporadic) forms of the disease (Corpet and Pierre, 2003) . In particular, the azoxymethane (AOM)-tumor model has been used extensively to identify molecular mechanisms involved in the multistage progression of sporadic CRCs (Corpet and Pierre, 2003) . In mice, repetitive administration of this methylating carcinogen produces noninvasive in situ adenocarcinomas, specifically within the distal colons of susceptible strains . More importantly, AOM-induced tumors in mice exhibit pathological and molecular features that recapitulate those seen in sporadic forms of the human disease (Wang et al., 1998; Guda et al., 2001; Nambiar et al., 2002; Dong et al., 2003) .
There is increasing evidence that genomic instability plays an important role in the progression of human colorectal tumors (Lindblom, 2001; Hoglund et al., 2002; Goel et al., 2003) . Two independent pathways of genomic instability have been identified; chromosomal (CIN) and microsatellite (MSI) instability (Fearon and Vogelstein, 1990; Lengauer et al., 1997) . CIN or the 'suppressor' pathway is the predominant form of genetic instability, manifested by widespread cytogenetic abnormalities, including chromosomal gains, losses, and rearrangements (Rajagopalan et al., 2003) . CIN and aneuploidy, however, are not random. In fact, chromosome banding analyses and comparative genomic hybridization (CGH) have firmly established that colorectal carcinomas are defined by a conserved distribution of chromosomal gains (7, 8q, 11q, 13q, and 20q ) and losses (1p, 18q, 8p, and 17p) Hermsen et al., 2002; Hoglund et al., 2002; Goel et al., 2003) . On the other hand, MSI or the 'mutator' pathway is characterized by the progressive accumulation of somatic alterations in the length of simple repeat nucleotide sequences known as microsatellites, and is a hallmark of tumors that develop within the colons of HNPCC patients. In addition, B10-15% of sporadic colorectal carcinoma cases show evidence of high-level MSI (MSI-H). MSI-H CRCs do not exhibit gross cytogenetic abnormalities and, in general, have a diploid karyotype (Lothe et al., 1993; Thibodeau et al., 1993; Olschwang et al., 1997; Eshleman et al., 1998) . While defects in the DNA mismatch repair system are attributable to an MSI phenotype, the precise molecular mechanisms leading to CIN remain to be elucidated Rajagopalan et al., 2003) .
The following study was undertaken to gain further insight into the molecular mechanisms that underlie AOM-induced colon tumorigenesis. We have undertaken a comprehensive set of studies to assess the potential contributions of CIN and MSI in carcinogeninduced tumors in A/J mice, using a combined approach of CGH and microsatellite analyses. Our results suggest that carcinogen-induced tumors may develop via mechanisms independent of the 'classical' CIN or MSI pathways, and that the tumors that form in A/J mice are representative of human adenomas or carcinomas in situ.
Results

Histopatholgic examination of AOM-induced colon tumors
Hematoxylin and eosin-stained sections were examined microscopically to confirm the histologic characteristics of AOM-induced colon tumors in A/J mice. These tumors display the typical features of an in situ adenocarcinoma, including marked cellular atypia, loss of goblet cell differentiation, nuclear pseudostratification, and a high nucleus to cytoplasmic ratio (Figure 1 ) . However, we rarely observe breachment of the basement membrane within the tumor mass and never find evidence for metastatic tumor dissemination . The histopathological evidence showing lack of invasion by the tumor crypts in the present study (Figure 1 ) further highlights these previous observations.
CIN is infrequent in carcinogen-induced colon tumors
Given the fact that CIN and aneuploidy are typically nonrandom events associated with human CRCs (Ried et al., , 1999 Hermsen et al., 2002; Hoglund et al., 2002; Goel et al., 2003; Rajagopalan et al., 2003) , we determined whether a specific pattern of chromosomal imbalance(s) also occurs in AOM-induced tumors. As shown in Table 1 , the majority (12/16) of AOM-induced tumors showed no gross chromosomal aberrations by CGH. The remaining four tumors displayed either a gain of chromosome 2 or loss of the Y chromosome (Table 1, Figure 2 ).
After completion of the CGH analysis in the primary tumors, we tested the extent of CIN in our recently Figure 1 Histologic appearance of an AOM-induced colon tumor. Representative photomicrograph of a hematoxylin and eosinstained in situ adenocarcinoma section from an A/J mouse. Note the exophytic appearance, marked cellular atypia, loss of goblet cell differentiation, nuclear pseudostratification, and a high nucleus-tocytoplasmic ratio with no evidence for submucosal invasion. T, tumor tissue; N, adjacent normal-appearing crypts 
The CGH and MSI profiles of A/J tumors and AJ02-NM 0 cells are shown in the Figure 3 ). Furthermore, of the 20 metaphase spreads analysed by SKY, no structural chromosomal rearrangements were evident, and the number of chromosomes per cell ranged from 74 to 78, indicating pseudo-tetraploidy (Figure 3 ). Despite the pseudo-tetraploidy observed in the AJ02-NM 0 cells by SKY analysis, CGH showed a relative loss of chromosomes 4 and 14 (Table 1) .
A/J colon tumors display low-level MSI
Since the majority of AOM-induced colon tumors lacked CIN, we evaluated the possibility that an MSI phenotype may be associated with this model. Accordingly, we screened a panel of 11 loci comprising two mono-and nine dinucleotide repeats for MSI. Furthermore, an additional set of two short mononucleotide repeats, JH102 and JH104, was analysed for insertion/ deletion mutations by direct DNA sequencing. Each sample analysed for MSI at a given locus was replicated three times and each replicate experiment was performed using a new PCR reaction. Visual observation of the peak patterns showed striking consistency between the three replicates for each sample. The tumors were then classified into distinct MSI categories based on the National Cancer Institute criteria described below. An MSI-L phenotype was evident in 13/16 tumors, of which 77% were unstable at two loci and 23% at one locus (Table 1) . Notably, all of the instabilities were restricted to dinucleotide repeats, an observation that is in agreement with earlier reports showing that alterations in mononucleotide runs are not characteristic of MSI-L cancers (Jass et al., 2002) . In all, 3/16 tumors were stable at each of the loci examined and were therefore categorized as MSS. The AJ02-NM 0 cell line, however, revealed an MSI-H phenotype with instability at nine loci ( Table 1 ). All of the MSI-L tumors, in addition to The role of K-ras, Apc, and b-catenin in the multistage progression of human colon cancers is firmly established (Calvert and Frucht, 2002; Kolligs et al., 2002) . In the present study, we examined the mutational status of the K-ras and Apc genes in AOM-induced tumors. With the exception of one tumor, which showed a GGT-GAT transition mutation in codon 12, none of the samples, including the AJ02-NM 0 cells, revealed mutations within exon 1 of the K-ras oncogene (Vogelstein et al., 1988; Kislitsin et al., 2002; Brink et al., 2003; Corpet and Pierre, 2003) . Furthermore, no sequence alterations were identified within the mutational cluster region (MCR) of the Apc gene (Fearnhead et al., 2001) . Immunohistochemical analysis of Apc using an antibody directed against the C-terminus showed no loss of protein expression in representative tumor sections, providing additional evidence for the absence of truncation mutations within the Apc gene ( Figure  5a-d) . Furthermore, the nuclear staining pattern of Apc (Figure 5a-d) is consistent with earlier studies demonstrating significant nuclear localization of this protein within colonic epithelial cells (Wong et al., 1996; Neufeld and White, 1997) . Despite the apparent lack of defects in the Apc protein, immunohistochemical analyses of b-catenin showed an intense nuclear accumulation in serially sectioned tumor epithelial cells (Figure 5e -h). On average, B60% of the cells within each tumor crypt showed strong nuclear staining for b-catenin. In the AOM-treated mice, tumor cells stained more intensely for b-catenin than adjacent normal tissue (Figure 5f and g). More importantly, while a bilateral membrane-staining pattern for b-catenin was evident in the adjacent non-neoplastic crypts, an intense nuclear accumulation with minimal membrane staining was observed within the tumor cells (Figure 5g ). Furthermore, no apparent changes in the staining intensity between the crypt epithelia and the surface columnar epithelial cells were observed in the non-neoplastic tissue (data not shown). Since b-catenin is the key downstream target of the Wnt signaling pathway, these data indicate that a pronounced disruption in this important proliferative pathway has occurred in A/J tumors.
Discussion
CIN and aneuploidy are predominant features of human CRCs and many other solid tumors (Ried et al., 1999; Rajagopalan et al., 2003) . In fact, CIN is by far the major form of genomic instability observed in the multi-step progression model of human CRCs Hermsen et al., 2002; Hoglund et al., 2002; Goel et al., 2003) . In the present study, using CGH and SKY, we show that the acquisition of recurrent chromosomal aneuploidies is a less common feature of both primary tumors and cultured cells from carcinogen-treated mice (Table 1, Figure 3 ). It should be noted, however, that there was one recurring aberration, a gain of chromosome 2 that was observed in 12.5% of the primary colon tumors (Table 1) . Interestingly, mouse chromosome 2 is partly orthologous to the q arm of human chromosome 20 that also shows a frequent gain in human CRCs (Human-Mouse Homology Map, Genomic instability in azoxymethane-induced mouse colon tumors K Guda et al be missed owing to the inherent limitation of CGH. Nevertheless, consistent with our findings, an earlier study in rats using genome-wide allelotyping showed that allelic imbalances are rare in AOM-induced (Wistar Furth Â Fischer 344) F1 rat colon tumors (Haag et al., 1999) . In contrast, Luceri et al. (2000) , using a random amplified polymorphic DNA method, showed evidence of genomic instability in colon tumors from AOM-treated male Fischer 344 rats. The discrepancy between these earlier studies may be a result of the different rat strains used or the methodology employed for measuring CIN. An alternative mechanism of genomic instability, the 'mutator' or the MSI pathway, results from a defective DNA mismatch repair system and is characterized by high-level instability in repeated nucleotide sequences. Such alterations may confer a selective growth advantage to cells during tumorigenesis, potentially resulting in frameshift mutations within several key tumorsuppressor genes that encode nucleotide repeats (Jass et al., 2002) . The National Cancer Institute has developed criteria to classify MSI into three categories based on a panel of microsatellite repeat markers as MSI-H, MSI-L, and MSS (Jass et al., 2002) . While most human CRCs typically show no evidence of MSI, approximately 10% of all sporadic and almost all HNPCC tumors display the 'mutator' phenotype . On the other hand, there is an emerging body of evidence to suggest that a MSI-L or 'mild mutator' phenotype may actually comprise a distinct tumorigenic pathway that may account for nearly 10% of sporadic cases of CRC (Iino et al., 1999; Jass et al., 1999 Jass et al., , 2002 Kambara et al., 2001; Whitehall et al., 2001; Jass, 2003) . However, the molecular and morphological criteria for distinguishing MSI-L from MSS remains controversial (Tomlinson et al., 2002; Jass, 2003) . Based on the significance of the MSI phenotypes and given the fact that CIN and MSI are, in general, mutually exclusive events in human CRCs (Lothe et al., 1993; Thibodeau et al., 1993; Olschwang et al., 1997; Eshleman et al., 1998) , we hypothesized that an MSI mechanism may be fundamental to the development of these chromosomally stable A/J tumors. Results showed a MSI-L in the majority of A/J tumors (Table 1, Figure 4 ), thereby suggesting the possibility for the presence of a 'mild mutator' mechanism active during carcinogen-induced tumorigenesis. If this is the case, then the expansion of MSI-L to MSI-H in the rapidly dividing AJ02-NM 0 cells (Table 1) may provide an experimental system for evaluating this possibility. It should be noted, however, that MSI, even at a low level, has seldom been observed in AOM-induced rat colon tumors (Haag et al., 1999; Walchle et al., 1999; Luceri et al., 2000) , suggesting species-specific differences in the molecular mechanisms underlying chemical carcinogenesis.
The limited extent of chromosomal imbalance and only MSI-L observed in the A/J primary tumors suggested the likelihood that defects present in other critical pathways, in particular Apc/b-catenin, may play an important role in carcinogen-induced tumorigenesis. Surprisingly, there were no sequence alterations identified within the MCR of the Apc gene (Fearnhead et al., 2001) . Further immunohistochemical analysis of Apc using an antibody directed against the C-terminus showed no loss of protein expression within representative tumor sections, providing additional evidence for the absence of truncation mutations within the Apc gene (Figure 5a-d) . Furthermore, the nuclear staining pattern of Apc (Figure 5a-d) is consistent with earlier studies demonstrating significant nuclear localization of this protein in the epithelial cells (Wong et al., 1996; Neufeld and White, 1997) . Nevertheless, our findings of intense nuclear accumulation of b-catenin (Figure 5e-h ) in the absence of Apc truncation mutations indicate a dysregulated Wnt signaling pathway in AOM-induced colon tumors and such an observation was supported by several previous studies in murine models (De Filippo et al., 1998; Sheng et al., 1998; Takahashi et al., 2000a, b; Corpet and Pierre, 2003) . However, one must not rule out the possibility that sequence alterations of the Apc gene may have occurred outside of the critical MCR that may adversely impact Wnt signaling.
In summary, we have investigated the role of genomic instability in a widely used colon carcinogen model. Our findings suggest that carcinogen-induced colon tumors may evolve via mechanisms that are independent of the classical 'suppressor' or 'mutator' pathway. These observations, however, do not rule out the significance of this animal model for studying colorectal tumorigenesis. In fact, several recent studies in human CRCs have also shown that a subset of human cancers do not fall within either of these two genetic pathways, regardless of tumor stage/grade (Georgiades et al., 1999; Chan et al., 2001; Goel et al., 2003) , suggesting that the molecular mechanisms leading to colorectal tumorigenesis are not necessarily defined by either the CIN or MSI pathways alone.
Materials and methods
Animals and treatment
Male A/J mice, 5-week old, were purchased from the Jackson Laboratories (Bar Harbor, ME, USA) and housed in a temperature-controlled environment (23711C) with a 12 h light/dark cycle. The mice were provided with Purina laboratory rodent chow and water ad libitum. After an acclimation period of 1 week, five mice were treated with AOM dissolved in 0.9% NaCl by intraperitoneal injections at a dose of 10 mg/kg body weight once a week for 6 weeks. An additional group of five mice received 0.9% NaCl alone and served as vehicle controls. Animals were killed 32 weeks after the last injection and tumors were harvested and evaluated by histomorphology. In all, 16 in situ adenocarcinomas (44 mm) were used for all subsequent analyses. A total of 15 normal distal colon sections were harvested from the vehicle control mice. Genomic DNA was extracted using QIAamp DNA Mini kit (Qiagen, Valencia, CA, USA) as per the manufacturer's instructions and used for subsequent CGH, MSI, and mutational analyses.
Cell culture
Murine tumor cells referred to as AJ02-NM 0 were derived from an A/J colon tumor. Briefly, excised primary colon tumors were minced and serially transferred into immunodeficient nude (Nu/Nu) mice (Charles River Laboratories, Wilmington, MA, USA). Following two subcutaneous serial passages, the tumor cells were excised, minced, and a portion seeded onto a p60 dish. After 24 h, the dish was rinsed and irradiated feeder layers (fibroblast-like cells isolated from previous attempts at growing AOM-induced colon tumors from the same mouse strain) were added. After a month in culture, two dense colonies were subcloned using glass-cloning rings to yield a rapidly growing population of cells determined to be free from cells displaying fibroblast-like morphology. The AJ02-NM 0 cells grew in the absence of feeder layers and were passed into larger flasks. A flask designated passage 1 was seeded approximately 45 days after subcloning. Chromosome spreads for SKY analysis were prepared on AJ02-NM 0 cells at passage 12. In parallel, genomic DNA was extracted from these cells using the QIAamp DNA Mini kit (Qiagen) and was used to perform CGH, MSI, and mutational analyses. RPMI supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA) served as the growth media for these cells.
Comparative genomic hybridization
DNA labeling, hybridization, and detection were performed as previously described (Weaver et al., 2002) . Briefly, 2 mg of DNA from primary tumors or AJ02-NM 0 cells and saline control colons were labeled with biotin-16-dUTP and digoxigenin-11dUTP (Boehringer Mannheim, Indianapolis, IN, USA), respectively, by nick translation, and were ethanol precipitated in the presence of 10 mg of salmon sperm DNA and 40 mg of the Cot-I fraction of mouse DNA (Gibco BRL, Gaithersburg, MD, USA). This labeled DNA probe was resuspended in 10 ml of hybridization solution (50% formamide, 2 Â sodium chloride and sodium citrate buffer (SSC), 10% dextran sulfate), denatured for 5 min at 801C, and preannealed at 371C for 1.5 h. Normal metaphase chromosomes from splenic cultures of C57BL/6 mice were dropped onto glass slides and pretreated with 0.1 mg/ml RNase (100 mg/ml), followed by 10 mg/ml pepsin in 0.01 M HCL. The chromosomes were denatured in 70% formamide, 2 Â SSC at 801C for 1.5 min prior to application of the probe DNA mixture. Hybridization was carried out at 371C for 72 h in a humidifying chamber. Probe signals were detected using an amplification procedure and counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI), as described previously (Weaver et al., 2002) . Images were acquired with a cooled chargecoupled device (CCD) camera (Roper Scientific, Tuscon, AZ, USA) mounted on a Leica DMRXA epifluorescence microscope (Leica, Wetzlar, Germany) using filters specific for DAPI, fluorescein, and rhodamine (Chroma Technologies, Brattleboro, VT, USA). CGH ratio profiles were calculated using Leica Chantal software (Leica Imaging Systems, Cambridge, UK) as described earlier (Weaver et al., 2002) .
Spectral karyotyping
Metaphase chromosomes for SKY hybridization were prepared from AJ02-NM 0 cells at passage 12. Cells in culture were incubated for 2 h in 0.02 mg/ml Colcemid (Invitrogen, Carlsbad, CA, USA). The cells were incubated in hypotonic solution (0.075 M KCl) and fixed in methanol : acetic acid (3 : 1). Spectral karyotyping was then performed as described previously, using a unique combination of five different fluorochromes (Liyanage et al., 1996; Weaver et al., 2002) . Images were acquired with SkyView software (Applied Spectral Imaging, Ltd, Migdal Haemek, Israel) using a spectral cube and a CCD camera (Hamamatsu, Bridgewater, NJ, USA) connected to a DMRXA microscope (Leica) with a custom SKY-3 optical filter (Chroma Technology). At least 20 metaphases were imaged and karyotyped using SkyView software.
MSI analysis
Two mononucleotide (uPAR, pro-1) (Kohonen-Corish et al., 2002) and nine dinucleotide (D1Mit62, D15Mit93, D17Mit72, D17Mit123, D17Mit185, D1Mit4, D7Mit17, D10Mit2, and D14Mit15) repeat markers were utilized to determine MSI status in primary tumors and AJ02-NM 0 cells. Primer sequences for all dinucleotide markers were obtained from the Whitehead Institute for Biomedical Research/Massachusetts Institute of Technology, Centre for Genome Research database (http://www.genome.wi.mit.edu). One primer from each primer pair was synthesized with a 5 0 fluorescent tag (FAM). PCR amplification was performed in a total volume of 50 ml, containing 50-100 ng of genomic DNA, 2.5 mM MgCl 2 , 0.2 mM each dATP, dGTP, dCTP, and dTTP, 0.25 mM each forward and reverse primers, and 1.25 U of Taq DNA polymerase (Invitrogen). PCR reactions were carried out in a PTC-200, Peltier Thermal Cycler (MJ research Inc, Reno, NV, USA), which included an initial denaturation at 941C for 2 min followed by 941C (45 s), 571C (30 s), and 721C (30 s) for 35 cycles, and a final elongation at 721C for 5 min. Fragments were visualized using an ABI 377 Sequencer (Applied Biosystems, Foster City, CA, USA). Data were analysed using Genescan and Genotyper software (Applied Biosystems). Colon tumors including AJ02-NM 0 cells were scored as having instability at a given locus if there was a significant shift in size, number of the peaks, and/or the pattern of microsatellite repeat regions when compared to the consistent pattern of peaks produced by the vehicle control colon samples. As an additional control experiment for AJ02-NM 0 cells, the microsatellite patterns from 11 markers were compared with those obtained from the tail DNA of immunodeficient nude (Nu/Nu) mice. To rule out artifacts inherent to the PCR process due to polymerase slippage, or to migration errors in the gel, instability at a marker locus was scored only when microsatellite alterations could be reproduced in repeat PCR reactions. Based on the National Cancer Institute criteria (Jass et al., 2002) , samples were then classified as MSI-H when 430% of marker loci examined showed signs of instability, MSI-L (instability at o30% of marker loci) or MSS (no instability at any of the markers examined). In addition, two short mononucleotide repeats, JH102 and JH104, which have been previously reported to be good indicators of instability in tumors of Mlh1-deficient mice (Kohonen-Corish et al., 2002) , were analysed for insertion-deletion mutations by direct sequencing in AOM-induced tumors and AJ02-NM 0 cells.
Screening for K-ras and Apc gene mutation
The K-ras oncogene was analysed for AOM-induced sequence alterations in A/J tumors and AJ02-NM 0 cells. PCR amplification for K-ras exon 1, using forward 5 0 -TGTAAGGCCTGCTGAAAATG-3 0 and reverse 5 0 -GCACGCAGACTGTAGAGCAG-3 0 primers, was carried out at 951C for 5 min followed by 951C (30 s), 551C (30 s), and 721C (45 s) for 35 cycles, and a final elongation at 721C for 5 min. The PCR products were then sequenced using ABI 377 sequencer (Applied Biosystems). Similarly, a 2.74 kb fragment in exon 15 of the Apc gene, which includes the MCR, was PCR amplified and analysed for sequence alterations using three sets of overlapping primers as previously described (Sohn et al., 2003) .
Apc and b-catenin immunohistochemistry
Formalin-fixed, paraffin-embedded mouse colon tumor and vehicle control tissue sections (5 mm) were subjected to antigen retrieval with 10 mM citrate buffer and incubated at 41C overnight with rabbit polyclonal anti-APC (C-20), raised against a peptide mapping to the carboxy terminus of the human APC protein (Santa Cruz Biotechnology, Santa Cruz, CA, USA), at a dilution of 1 : 20 in PBS. Sections were washed with PBS/Brij and incubated with biotinylated goat anti-rabbit immunoglobulin G (Vector Laboratories, Burlingame, CA, USA) at a dilution of 1 : 200 at room temperature for 30 min. After washing, the sections were incubated with avidin-biotin peroxidase complex provided by Vectastain Elite ABC kit (Vector Laboratories) at room temperature for 30 min. Color was developed with 3,3-diaminobenzidine as the substrate and the sections were counterstained with 0.5% methyl green. As a negative control, duplicate sections were immunostained with rabbit IgG in place of the APC primary antibody. In addition, a similar analysis was performed on serial sections obtained from the same tissues, except that they were not subjected to the antigen-retrieval procedure before incubating with the primary antibody. Furthermore, the procedure was repeated with a second APC antibody obtained from a different batch (Santa Cruz Biotechnology). For b-catenin immunostaining, serial sections of A/J tumors and vehicle-treated control colons were incubated at 41C overnight with mouse monoclonal antib-catenin antibody (Sigma-Aldrich, St Louis, MO, USA) at a dilution of 1 : 1000 in 10% normal goat serum. The sections were then washed and incubated with biotinylated goat antimouse immunoglobulin G at a dilution of 1 : 100 (Vector Laboratories, Burlingame, CA, USA) at room temperature for 30 min. After washing, the sections were incubated with avidin-biotin peroxidase complex at room temperature for 30 min using the Vectastain Elite ABC kit (Vector laboratories). Color was developed using 3,3 0 -diaminobenzidine substrate and sections were counterstained with 0.5% methyl green (Trevigen Inc., Gaithersburg, MD, USA). As a negative control, duplicate sections were immunostained with mouse IgG in place of the primary b-catenin antibody. Furthermore, Apc and b-catenin-positive cells were counted in a minimum of 10 different high magnification ( Â 400) fields per section.
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